OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical & Translational Immunology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Endothelial cells are not productively infected by SARS‐CoV‐2	86
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients	73
CAR‐NK cells: the next wave of cellular therapy for cancer	65
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination	60
Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand	47
Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2	45
Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors	44
Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models	42
Pattern of circulating SARS‐CoV‐2‐specific antibody‐secreting and memory B‐cell generation in patients with acute COVID‐19	41
Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells in vitro	39
Rheumatoid arthritis CD14⁺ monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease	38
Arrested development: suppression of NK cell function in the tumor microenvironment	36
SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation	34
Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019	34
Decline in neutralising antibody responses, but sustained T‐cell immunity, in COVID‐19 patients at 7 months post‐infection	34
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4⁺ and CD8⁺ T‐cell protective responses to breast cancer	34
RGD‐binding integrins and TGF‐β in SARS‐CoV‐2 infections – novel targets to treat COVID‐19 patients?	32
Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease	31
The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders	30
The up‐to‐date pathophysiology of Kawasaki disease	30
Natural killer cells in inflammatory autoimmune diseases	29
Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease	29
Cardiovascular disease in SARS‐CoV‐2 infection	28
Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features	26
Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant	26

Lysine methyltransferase G9a is an important modulator of trained immunity	25
Ligelizumab treatment for severe asthma: learnings from the clinical development programme	25
Influenza, but not SARS‐CoV‐2, infection induces a rapid interferon response that wanes with age and diminished tissue‐resident memory CD8⁺ T cells	25